HNN3.0

Project cooperationUpdated on 22 December 2025

Postbitic for glycemic control (type 2 diabetes, prediabetes)

R&D Manager at GENBIOMA

Pamplona, Spain

About

Genbioma is a start-up that studies the microbiome to create products that improve cardiometabolic health.

Health Solutions

G​enbioma advances metabolic wellness with postbiotic ingredients that restores gut-microbiota balance to steady glucose, harmonise lipid profiles and support healthy weight. Our most advanced product is intended for type 2 diabetes and prediabetes. Other products in our pipeline are aimed at lipid metabolism.

Research platform

Genbioma has validated a development platform for rapid identification and functional profiling of new microbiome-based solutions.

  • Array of validated assays for glucose, lipid and cardiovascular metabolism using C. elegans model.

  • Integrated metagenomics & metabolomics to unveil mode-of-action early.

  • Regulatory filters baked in: Safety, IP and regulatory checkpoints for early candidate de-selection.

Expertise

Microbiome study. Postbiotics, probiotics. Preclinical and clinical studies. Metagenomics.

Similar opportunities